1-2-3 Cancer Treatment Plan
![]() ![]() |
Low dose naltrexone (LDN) against cancerCancer Core / Also "NON-STAGE IV / Add-On treatment |
Prescribed 'off-label', Naltrexone (generic name) is a prescription opioid antagonist druggiven at unconventionally low doses showing great promise in treating autoimmune diseases (including central nervous system disorders), cancer, HIV/AIDS and COPD.
For more information on LDN:
Low Dose Naltrexone(LDN) - Immune regulatorfor Auto-Immune Diseases + Cancer, AIDS, COPD and the common cold
LDN is used:
As a preventive treatment against cancer
To prevent a recurrence of cancer
To treat cancer - LDN has been shown in many cases to work with virtually incurable cancers such as neuroblastoma, multiple myeloma, and pancreatic cancer.
Research on neuropeptide receptors expressed by various human tumors has found opioid receptors in many types of cancer:
Increased endorphin production and other related factors linked to anti-cancer mechanisms - Dr. Bernard Bihari, who first discovered LDN as a therapeutic agent for AIDS, in 1985, believes LDNs anti-cancer mechanism is likely due to an increase in:
▲ Increased endorphins (morphine-like substances originating from inside the body)
▲ Number and density of opiate receptors on the tumor cell membranes - making them more responsive to the growth-inhibiting effects of the already present levels of endorphins, which in turn induces apoptosis (cell death) in the cancer cells
▲ The absolute numbers of circulating cytotoxic T-cells and natural killer cells - as well as killer cell activity
Dr. Bihari reports promising results in treating 450+ cancer patients with LDN -, including cancers of the bladder, breast, liver, lung, lymph nodes, colon, and rectum. According to Dr. Bihari, close to a quarter of his patients had at least a 75% reduction in tumor size, and nearly 60% of his patients demonstrated disease stability.
Dr Ian Zagon has shown in one study that LDN can stop breast cancer cells growing in multiple resistant breast cancer -by a mechanism that acts on the 'p21 cyclin-dependent inhibitory kinase pathway, present in many solid tumors and a large proportion of breast cancers
http://www.sciencedaily.com/releases/2013/08/130810063639.htm
http://ldnresearchtrust.org/sites/default/files/LDN%20Information%20Pack(1).pdf
The Berkson Method is a cancer therapy that combines LDN and Alpha Lipoic Acid
http://www.anticancer.org.uk/2011/10/q-with-dr-burt-berkson-low-dose.html